trauma-list Digest, Vol 48, Issue 28

[Kashuk, Jeffry]

 Octreotide's primary use seems to be to decrease volume in high output
fistulae,(which can be helpful with regard to wound care as well as
fluid and electrolyte issues) but it does not seem to decrease the rate
of spontaneous closure or the ultimate duration of the fistula in most
literature reports....
 We preach to the residents that in the majority of situations, the
cornerstone of management should be adequate drainage, infection
control, evaluation of obstruction or stricture, and nutrition rather
than the octreotide..hence, we rarely use it.
Jeffry L. Kashuk, M.D, FACS
Surgery, Trauma, Surgical Critical Care
Denver Health Medical Center
777 Bannock St, MC 0206
Denver, CO 80204
Ph 303-436-6558
Fax 303-436-6572


-----Original Message-----
From: trauma-list-bounces at trauma.org
[mailto:trauma-list-bounces at trauma.org] On Behalf Of
trauma-list-request at trauma.org
Sent: Thursday,June 28,2007 5:00 AM
To: trauma-list at trauma.org
Subject: trauma-list Digest, Vol 48, Issue 28

Send trauma-list mailing list submissions to
	trauma-list at trauma.org

To subscribe or unsubscribe via the World Wide Web, visit
	http://list.mistral.net/mailman/listinfo/trauma-list
or, via email, send a message with subject or body 'help' to
	trauma-list-request at trauma.org

You can reach the person managing the list at
	trauma-list-owner at trauma.org

When replying, please edit your Subject line so it is more specific than
"Re: Contents of trauma-list digest..."


------------------------------------------------------------------------------
CONFIDENTIALITY NOTICE - This e-mail transmission, and any documents, files or previous e-mail messages attached to it may contain information that is confidential or legally privileged.  If you are not the intended recipient, or a person responsible for delivering it to the intended recipient, you are hereby notified that you must not read this transmission and that any disclosure, copying, printing, distribution or use of any of the information contained in or attached to this transmission is STRICTLY PROHIBITED.  If you have received this transmission in error, please immediately notify the sender by telephone or return e-mail and delete the original transmission and its attachments without reading or saving in any manner.  Thank you.

==============================================================================